FI57417C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerad-oxazolo-(4,5-b)-pyridiner - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerad-oxazolo-(4,5-b)-pyridiner Download PDFInfo
- Publication number
- FI57417C FI57417C FI1657/73A FI165773A FI57417C FI 57417 C FI57417 C FI 57417C FI 1657/73 A FI1657/73 A FI 1657/73A FI 165773 A FI165773 A FI 165773A FI 57417 C FI57417 C FI 57417C
- Authority
- FI
- Finland
- Prior art keywords
- oxazolo
- acid
- pyridine
- preparation
- butyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI800611A FI58921C (fi) | 1972-06-14 | 1980-02-28 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerade-oxazolo-(5,4-b)-pyridiner |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26289872A | 1972-06-14 | 1972-06-14 | |
US26289872 | 1972-06-14 | ||
BE147896A BE819177R (fr) | 1972-06-14 | 1974-08-26 | Oxazolo- et thiazolopyridines |
BE147896 | 1974-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI57417B FI57417B (fi) | 1980-04-30 |
FI57417C true FI57417C (fi) | 1980-08-11 |
Family
ID=25648082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI1657/73A FI57417C (fi) | 1972-06-14 | 1973-05-22 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerad-oxazolo-(4,5-b)-pyridiner |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5943475B2 (cs) |
AR (1) | AR208500A1 (cs) |
AT (1) | AT333277B (cs) |
AU (1) | AU472528B2 (cs) |
BE (2) | BE800868A (cs) |
CA (1) | CA1019741A (cs) |
CS (1) | CS178889B2 (cs) |
DD (1) | DD105237A5 (cs) |
DE (1) | DE2330109A1 (cs) |
DK (1) | DK152050C (cs) |
FI (1) | FI57417C (cs) |
FR (1) | FR2187356B1 (cs) |
GB (1) | GB1421619A (cs) |
LU (1) | LU67786A1 (cs) |
NL (1) | NL184836C (cs) |
SE (2) | SE401675B (cs) |
ZA (1) | ZA733760B (cs) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2527321A1 (de) * | 1975-06-19 | 1976-12-23 | Merck & Co Inc | Oxazol eckige klammer auf 4,5-b eckige klammer zu pyridine |
JPS527992A (en) * | 1975-07-04 | 1977-01-21 | Merck & Co Inc | Oxazolo *4*55b* pyridines |
NL187021C (nl) * | 1975-07-15 | 1991-05-01 | Merck & Co Inc | Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte anti-inflammatoir werkzame 2-fenyl-oxazolo-(4,5-b)pyridinederivaten. |
US4011326A (en) * | 1975-07-29 | 1977-03-08 | Merck & Co., Inc. | 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents |
US4753673A (en) * | 1977-07-22 | 1988-06-28 | The Dow Chemical Company | Trifluoromethyl pyridinyloxyphenoxy and pyridinylthiophenoxy propanoic acids and propanols and derivatives thereof and methods of herbicidal use |
DE2862462D1 (de) * | 1977-08-12 | 1985-05-15 | Ici Plc | 2-chloro-5-trichloromethylpyridine |
JPS5461182A (en) * | 1977-10-20 | 1979-05-17 | Ishihara Sangyo Kaisha Ltd | 2-phenoxy-5-trifluoromethylpyridine compounds |
JPS5461183A (en) * | 1977-10-21 | 1979-05-17 | Ishihara Sangyo Kaisha Ltd | 2-substituted-5-trifluoromethyl pyridine compounds |
JPH0224818B2 (cs) * | 1978-02-15 | 1990-05-30 | Imuperiaru Chem Ind Plc | |
JPS55130840U (cs) * | 1979-03-12 | 1980-09-16 | ||
JPS55124763A (en) * | 1979-03-19 | 1980-09-26 | Ishihara Sangyo Kaisha Ltd | 5-trifluoromethyl-2-pyridone derivative |
GB8333514D0 (en) * | 1983-12-16 | 1984-01-25 | Erba Farmitalia | Tetrahydrothiazolo(5 4-c)pyridine derivatives |
FR2652085A1 (fr) * | 1989-09-20 | 1991-03-22 | Science Organisation | Nouveau procede de synthese de derives d'oxazolopyridines. |
DE59711147D1 (de) * | 1996-11-11 | 2004-01-29 | Altana Pharma Ag | Neue Imidazo- und Oxazolopyridine als Phosphodiesterase Inhibitoren. |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
TR200100189T2 (tr) * | 1998-06-04 | 2001-05-21 | Abbott Laboratories | Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler |
HK1045306A1 (zh) * | 1999-06-03 | 2002-11-22 | Abbott Laboratories | 抑制细胞黏附的抗炎化合物 |
WO2002036580A2 (en) * | 2000-10-31 | 2002-05-10 | Lynn Bonham | Benzoxazole lpaat- beta inhibitors and uses thereof |
US8093401B2 (en) | 2005-08-04 | 2012-01-10 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
US7855289B2 (en) | 2005-08-04 | 2010-12-21 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
AU2006278504B2 (en) | 2005-08-04 | 2013-01-17 | Sirtris Pharmaceuticals, Inc. | Imidazopyridine derivatives as sirtuin modulating agents |
US8088928B2 (en) | 2005-08-04 | 2012-01-03 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
TW200916472A (en) | 2007-06-20 | 2009-04-16 | Sirtris Pharmaceuticals Inc | Sirtuin modulating compounds |
JP5734853B2 (ja) * | 2008-08-29 | 2015-06-17 | トレヴェンティス コーポレイションTreventis Corporation | 神経系疾患用の診断ツール及び治療としてのブチリルコリンエステラーゼリガンド |
NZ594122A (en) | 2008-12-19 | 2013-03-28 | Sirtris Pharmaceuticals Inc | 2-Phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide derivatives |
TW201114762A (en) * | 2009-09-30 | 2011-05-01 | Sumitomo Chemical Co | Composition and method for controlling arthropod pests |
CA2812087A1 (en) * | 2010-09-15 | 2012-03-22 | F. Hoffmann-La Roche Ag | Azabenzothiazole compounds, compositions and methods of use |
US8853238B2 (en) * | 2010-12-24 | 2014-10-07 | Sumitomo Chemical Company, Limited | Fused heterocyclic compound and use thereof for pest control |
WO2015200650A1 (en) * | 2014-06-25 | 2015-12-30 | Epizyme, Inc. | Substituted benzene and 6,5-fused bicyclic heteroaryl compounds |
EP3227302B1 (de) | 2014-12-02 | 2018-07-11 | Bayer CropScience AG | Bicyclische verbindungen als schädlingsbekämpfungsmittel |
US10399966B2 (en) | 2016-01-21 | 2019-09-03 | University Of Washington | Compounds for treatment of trypanosomes and neurological pathogens and uses thereof |
JP7430486B2 (ja) * | 2016-07-07 | 2024-02-13 | 保土谷化学工業株式会社 | ベンゾアゾール環構造を有する化合物および有機エレクトロルミネッセンス素子 |
-
1973
- 1973-03-12 AR AR248527A patent/AR208500A1/es active
- 1973-05-22 FI FI1657/73A patent/FI57417C/fi active
- 1973-05-24 DK DK284973A patent/DK152050C/da not_active IP Right Cessation
- 1973-05-25 SE SE7307412A patent/SE401675B/xx unknown
- 1973-05-30 NL NLAANVRAGE7307582,A patent/NL184836C/xx not_active IP Right Cessation
- 1973-06-04 ZA ZA00733760A patent/ZA733760B/xx unknown
- 1973-06-04 AU AU56511/73A patent/AU472528B2/en not_active Expired
- 1973-06-05 CA CA173,275A patent/CA1019741A/en not_active Expired
- 1973-06-08 AT AT508673A patent/AT333277B/de active
- 1973-06-11 GB GB2763273A patent/GB1421619A/en not_active Expired
- 1973-06-12 DD DD171559A patent/DD105237A5/xx unknown
- 1973-06-12 CS CS7300004243A patent/CS178889B2/cs unknown
- 1973-06-13 FR FR7321443A patent/FR2187356B1/fr not_active Expired
- 1973-06-13 DE DE2330109A patent/DE2330109A1/de not_active Withdrawn
- 1973-06-13 LU LU67786A patent/LU67786A1/xx unknown
- 1973-06-13 BE BE132231A patent/BE800868A/xx not_active IP Right Cessation
- 1973-06-14 JP JP48066453A patent/JPS5943475B2/ja not_active Expired
-
1974
- 1974-08-26 BE BE147896A patent/BE819177R/xx not_active IP Right Cessation
-
1976
- 1976-04-14 SE SE7604385A patent/SE432767B/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BE819177R (fr) | 1975-02-26 |
FR2187356B1 (cs) | 1977-01-28 |
DK152050B (da) | 1988-01-25 |
DD105237A5 (cs) | 1974-04-12 |
GB1421619A (en) | 1976-01-21 |
JPS5943475B2 (ja) | 1984-10-22 |
JPS4961195A (cs) | 1974-06-13 |
CS178889B2 (en) | 1977-10-31 |
FR2187356A1 (cs) | 1974-01-18 |
NL7307582A (cs) | 1973-12-18 |
AU5651173A (en) | 1974-12-05 |
CA1019741A (en) | 1977-10-25 |
SE7604385L (sv) | 1976-04-14 |
LU67786A1 (cs) | 1973-08-16 |
AT333277B (de) | 1976-11-10 |
DE2330109A1 (de) | 1974-01-03 |
ATA508673A (de) | 1976-03-15 |
AU472528B2 (en) | 1976-05-27 |
BE800868A (fr) | 1973-12-13 |
SE401675B (sv) | 1978-05-22 |
NL184836C (nl) | 1989-11-16 |
ZA733760B (en) | 1975-01-29 |
AR208500A1 (es) | 1977-02-15 |
NL184836B (nl) | 1989-06-16 |
DK152050C (da) | 1988-07-18 |
FI57417B (fi) | 1980-04-30 |
SE432767B (sv) | 1984-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI57417C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerad-oxazolo-(4,5-b)-pyridiner | |
DE69330715T2 (de) | Antitumor quinazoline | |
AU2018269348B2 (en) | Histone deacetylases (HDACs) inhibitors | |
FI68050C (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara 2-asylaminometyl-1h-2,3-dihydro-1,4-benzodiazepiner | |
NO151320B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider | |
JPH02117664A (ja) | 4‐ピリドン‐3‐カルボン酸およびその誘導体 | |
FR2492382A1 (fr) | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique | |
UA43841C2 (uk) | Імідазопіридини та фармацевтична композиція на їх основі | |
CA2104883A1 (fr) | Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant | |
RU2001910C1 (ru) | Способ получени хинолинового производного | |
CA1108138A (en) | Triazine derivatives | |
EP0011142B1 (de) | Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate | |
Binder et al. | Analogs and derivatives of tenoxicam. 1. Synthesis and antiinflammatory activities of analogs with different residues on the ring nitrogen and the amide nitrogen | |
JPS623153B2 (cs) | ||
JPH0471914B2 (cs) | ||
EP0008226B1 (en) | Phenyl-alkanoic acid derivatives, the preparation thereof and pharmaceutical compositions containing them | |
CH653036A5 (de) | Substituierte thiazolo-(3,2-a)-pyrimidine. | |
JPH0710863B2 (ja) | エーテル化若しくはエステル化しうるジヒドロキシ基により位置2で置換された4―ohキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用 | |
NZ199318A (en) | 2-phenyl(carbonyl or alkanoyl)aminomethyl-1,2-dihydro-3h-1,4-benzodiazepines | |
US4044134A (en) | Fused pyrimidin-4(3H)-ones as antiallergy agents | |
US4873232A (en) | Novel use for carbamoyl benzoates | |
NO131345B (cs) | ||
FI58921C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-substituerade-oxazolo-(5,4-b)-pyridiner | |
US4134981A (en) | Pyrimidal [2,3,d]Pyrimidin-4(3H)-ones as antiallergy agents | |
US3968213A (en) | Method of preventing asthmatic symptoms |